Yes, a single formula can be sold in both markets, but the label, claims language, and regulatory documentation must be handled separately for each jurisdiction. The formula itself rarely needs to change — the same adaptogen extracts that are permitted in the US are generally permitted in the EU — but there are a few ingredient-level exceptions to check.
In the EU, some botanical extracts are restricted or require specific maximum concentrations under the EU Cosmetics Regulation annexes. Before assuming your US formula clears EU import, have the full INCI list reviewed by an EU Responsible Person or regulatory consultant. Certain preservative systems common in US formulas (e.g., formaldehyde-releasing preservatives like DMDM hydantoin) are banned in the EU and would require reformulation.
Documentation requirements diverge significantly. For the US under MoCRA, you need facility registration and product listing on file with FDA. For the EU, you need a Cosmetic Product Safety Report (CPSR) from a qualified EU safety assessor, product notification in the CPNP portal, and a physical EU Responsible Person (a legal entity based in the EU who can be contacted by authorities). The CPSR process typically costs $500–$2,000 per product and takes four to eight weeks.
Label language must be adapted for each market. EU labels require the full INCI list, the name and address of the EU Responsible Person, and any applicable special warnings under EU Annexes. US labels require net weight in both metric and US customary units, a domestic address, and ingredient declaration in descending order of concentration. Claims language must be separately reviewed for each market because the line between cosmetic and drug claims is drawn differently by FDA versus the EU Cosmetics Regulation.
For founders building a global launch from the start, the most cost-effective approach is to choose a manufacturer with EU export experience and have the CPSR commissioned during the same window as US stability testing, rather than treating EU registration as a later phase. This typically adds $1,000–$3,000 and four to eight weeks to the overall timeline but avoids a full relaunch cycle.
Read the full guide on Private Label Adaptogen Skincare Serum Manufacturer Low MOQ →